Advertisement
Liquidia Corporation

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

LQDA●NASDAQ
HealthcareBiotechnology
$62.54
$6.85(12.30%)
U.S. Market opens in 16h 7m
Advertisement

Liquidia Corporation (LQDA)

Meyka AI Score

Z

Key Financials

Market Cap5.6B
P/E Ratio216.08
EPS (TTM)$0.17
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$33.83
3 Months$43.76
1 Year Target$49.34

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 66.48, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 216.08 and a market capitalization of 5.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
12.30%
5-Day Change
1.69%
1-Month Change
62.53%
3-Month Change
81.91%
6-Month Change
84.38%
Year-to-Date (YTD) Change
81.33%
1-Year Change
255.34%
3-Year Change
612.30%
5-Year Change
2079.09%
All-Time (Max) Change
463.42%

Contact Information

https://www.liquidia.com
919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

170 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions